[Federal Register Volume 66, Number 154 (Thursday, August 9, 2001)]
[Notices]
[Page 41878]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-19958]



[[Page 41878]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates: 8:30 a.m.--5:00 p.m., September 12, 2001; 8:30 
a.m.--3:30 p.m., September 13, 2001
    Place: CDC, Koger Center, Williams Building, Conference Rooms 
1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health and Surgeon General, 
and the Director, CDC, regarding the need for, and the nature of, 
revisions to the standards under which clinical laboratories are 
regulated; the impact on medical and laboratory practice of proposed 
revisions to the standards; and the modification of the standards to 
accommodate technological advances.
    Matters To Be Discussed: The agenda will include updates from 
CDC, Food and Drug Administration and Centers for Medicare & 
Medicaid Services (formerly the Health Care Financing 
Administration), Unregulated Tests Workgroup report, report on the 
Secretary's Advisory Committee on Genetic Testing, discussion of 
communication strategies and manufacturer's pre-market clearance 
submission and good manufacturing practices.
    Agenda items are subject to change as priorities dictate.

FOR FURTHER INFORMATION CONTACT: Rhonda Whalen, Chief, Laboratory 
Practice Standards Branch, Division of Laboratory Systems, Public 
Health Practice Program Office, CDC, 4770 Buford Highway, NE, Mailstop 
F-11, Atlanta, Georgia 30341-3724, telephone 770/488-8042, fax 770/488-
8279.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: August 3, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 01-19958 Filed 8-8-01; 8:45 am]
BILLING CODE 4163-18-P